Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial

INTRODUCTION: The objective of this study was to assess the impact of certolizumab pegol (CZP) treatment on health-related quality of life (HRQoL), fatigue and other patient-reported outcomes (PROs) in patients with rheumatoid arthritis (RA). METHODS: Patients with active RA (N = 982) were randomize...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Strand, Vibeke, Mease, Philip, Burmester, Gerd R, Nikaï, Enkeleida, Coteur, Geoffroy, van Vollenhoven, Ronald, Combe, Bernard, Keystone, Edward C, Kavanaugh, Arthur
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2009
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3003523/
https://ncbi.nlm.nih.gov/pubmed/19909548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar2859
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki